TherapeuticsMD, Inc. Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31)
TherapeuticsMD, Inc. (TXMD) reported Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) of 1.95 million shares for the 1-month period ending 2013-04-30, per its 10-Q filed 2013-05-10.
Discontinued › Notes
us-gaap:StockIssuedDuringPeriodSharesIssuedForCash · last filed 2013-05-10
- 2013-04-30: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month 1.95M shares.
- 2013-03-31: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month 29.41M shares.
| Period end | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month |
|---|---|
| 2013-04-30 | 1.95M shares 10-Q · filed 2013-05-10 |
| 2013-03-31 | 29.41M shares 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |